• no-js

About MORU

The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases such as melioidosis, typhus, TB and leptospirosis.

MORU was established in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the UK’s Wellcome Trust.

MORU’s main office and laboratories are located within the Faculty of Tropical Medicine at Mahidol University in Bangkok, Thailand, with MORU study sites and collaborations across Thailand, Asia and Africa.

MORU is generously supported with significant funding from the Wellcome Trust, our major funding partner. We also receive funding from other trusts and foundations, governments, and multi-lateral donors.

 

Read more about MORU

Recent Publications

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions. Trials, 20 (1), pp. 111. Article

Estimating malaria disease burden in the Asia-Pacific . Article

Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case . Article

Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data. BMC Med, 17 (1), pp. 70. Article

See all recent publications